Provided by Tiger Trade Technology Pte. Ltd.

Disc Medicine

74.53
+0.39000.53%
Volume:24.69K
Turnover:1.84M
Market Cap:2.86B
PE:-11.36
High:75.00
Open:74.66
Low:74.50
Close:74.14
52wk High:99.50
52wk Low:40.00
Shares:38.39M
Float Shares:32.95M
Volume Ratio:1.13
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.5619
EPS(LYR):-6.0116
ROE:-39.08%
ROA:-23.96%
PB:4.44
PE(LYR):-12.40

Loading ...

Disc Medicine to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 11

Disc Medicine (IRON) Gets a Buy from LifeSci Capital

TIPRANKS
·
May 10

Disc Medicine (IRON) Receives a Buy from H.C. Wainwright

TIPRANKS
·
May 07

Disc Medicine Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

Disc Medicine reports Q1 EPS ($1.65), consensus ($1.73)

TIPRANKS
·
May 05

Disc Medicine posts smaller-than-expected Q1 net loss

Reuters
·
May 05

Disc Medicine Q1 EPS $(1.65) Beats $(1.73) Estimate

Benzinga Earnings
·
May 05

Earnings Flash (IRON) Disc Medicine Posts Q1 Net Loss $1.65 a Share, vs. FactSet Est of $1.65 Loss

MT Newswires Live
·
May 05

Disc Medicine Q1 Net Income USD -63.504 Million VS. Ibes Estimate USD -67.1 Million

THOMSON REUTERS
·
May 05

Press Release: Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
May 05

How Investors Are Reacting To Disc Medicine (IRON) After FDA Letter Triggers Shareholder Investigation

Simply Wall St.
·
May 05

Press Release: LABRADOR IRON ORE ROYALTY CORPORATION - RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2026

Dow Jones
·
May 05

Press Release: CHAMPION IRON REPORTS ITS FY2026 FOURTH QUARTER PRODUCTION AND SALES

Dow Jones
·
Apr 30

Disc Medicine announces annual shareholder meeting via webcast

Reuters
·
Apr 29

Mabwell Q1 net loss narrows to RMB 241.94 million; revenue triples to RMB 127.6 million

Reuters
·
Apr 28

Will Insider 10b5-1 Sales and New ASCO Data Shift Disc Medicine's (IRON) Narrative?

Simply Wall St.
·
Apr 24

Disc Medicine Completes Key Phase 1b Study of DISC-0974 in CKD Anemia: What Investors Should Watch

TIPRANKS
·
Apr 24

Disc Medicine to present Phase 2 RALLY-MF data for DISC-0974 at ASCO 2026

Reuters
·
Apr 21

Disc Medicine Announces Oral Presentation of Data From Rally-Mf Phase 2 Trial of Disc-0974 in Patients With Myelofibrosis and Anemia at the American Society of Clinical Oncology (Asco) Annual Meeting

THOMSON REUTERS
·
Apr 21

Disc Medicine CMO William Jacob Savage disposes of $379,087 common shares

Reuters
·
Apr 16